Biggest News Aggregation in the World
📰 Autonomous Diagnostics News

Autonomous Diagnostics News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Autonomous Diagnostics. Real-time updates on events, politics, business and more.

DARPA Awards Moderna Therapeutics a Grant for up to $25 Million to Develop Messenger RNA Therapeutics™

October 2, 2013 at 9:00 AM EDT Research to focus on antibody production for immune defense CAMBRIDGE, Mass., October 2, 2013—Moderna Therapeutics, the company pioneering messenger RNA therapeutics™, a revolutionary new treatment modality to enable the  in vivo production of therapeutic proteins, announced today that the Defense Advanced Research Projects Agency (DARPA) has awarded the company up to $25 million to research and develop its messenger RNA therapeutics™ platform as a rapid ...
United Kingdom United States Defense Advanced Research Projects Agency Moderna Therapeutics Autonomous Diagnostics Enable Prevention

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Is DARPA implantable microchip to detect COVID-19 the mark of the beast?

Is DARPA implantable microchip to detect COVID-19 the mark of the beast? (Photo credit: Shutterstock.com / Gorodenkoff) The Defense Advanced Research Projects Agency, commonly referred to as DARPA, was established during the Cold War more than 60 years ago. For 60 years, DARPA has maintained and advanced the mission of making “pivotal investments in breakthrough technologies for national security.” Many are familiar with their human and animal-like robots, but recently, they have ta...
Bill Whitaker Matt Hepburn Department Of Defense Do Technologies Office Defense Advanced Research Projects Agency White House National Security Staff

Heru, Inc., A 3 Seasons Capital, LLC Portfolio Medical Technology Company, Receives Class 1 Listing With the FDA for Developing a Next-Generation, Artificial Intelligence (AI)-Driven Platform for Vision Diagnostics and Augmentation

TMCnet News Heru, Inc., A 3 Seasons Capital, LLC Portfolio Medical Technology Company, Receives Class 1 Listing With the FDA for Developing a Next-Generation, Artificial Intelligence (AI)-Driven Platform for Vision Diagnostics and Augmentation [December 28, 2020] Heru, Inc., A 3 Seasons Capital, LLC Portfolio Medical Technology Company, Receives Class 1 Listing With the FDA for Developing a Next-Generation, Artificial Intelligence (AI)-Driven Platform for Vision Diagnostics and Augmentation MIA...
United States University Of Miami Hospital Fred Drasner Eduardoc Alfonso Ken Frydman Heru Inc
Source: tmcnet.com

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science